Most Cancer Patients Prepared To Delay Treatment To Benefit From Personalized Care
In patients with metastatic colorectal cancer (mCRC), the survey found that almost half remain unaware that a KRAS biomarker test can determine whether a targeted therapy could be effective for them.1
Also, 73% of mCRC patients would be willing to delay initiation of treatment by two weeks or more (the average turnaround time for KRAS test results) to be prescribed a therapy that is targeted and effective, with around a third (31%) stating they would be prepared to wait 'as long as it takes'.1 Almost three quarters (73%) of mCRC patients would be willing to undergo a re-biopsy if necessary.1
"KRAS testing and other biomarker tests can be beneficial in the management of patients, and it would be useful to have these tests conducted as early as possible," said Professor Sabine Tejpar, Digestive Oncology Unit, University Hospital Gasthuisberg, Leuven, Belgium, and lead study author. "However, this new survey shows that patients with metastatic colorectal cancer are less likely to be given a biomarker test and a targeted therapy at diagnosis than those with other cancers. This can lead to suboptimal treatment and unnecessary additional investigations, including re-biopsy, before an appropriate 1st-line targeted therapy is given."
About Colorectal Cancer
CRC is the second most common cancer worldwide, after breast cancer.6 Overall mortality caused by CRC varies according to local screening practices, and the stage at which the disease is diagnosed.7 Approximately 608,000 people worldwide die from the disease each year, accounting for 8% of all cancer deaths, making it the fourth most common cause of death from cancer.8
1. Tejpar S, et al. ESMO 2012 Congress; ESMO ID 1382P.
Please use one of the following formats to cite this article in your essay, paper or report:
Serono, Merck. "Most Cancer Patients Prepared To Delay Treatment To Benefit From Personalized Care." Medical News Today. MediLexicon, Intl., 2 Oct. 2012. Web.
23 Feb. 2017. <http://www.medicalnewstoday.com/releases/250920.php>
Serono, M. (2012, October 2). "Most Cancer Patients Prepared To Delay Treatment To Benefit From Personalized Care." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.